Commercial influenza vaccines vary in both the structural arrangements of HA complexes and in induction of antibodies to cross-reactive HA epitopes
M. L. Myers, J. R. Gallagher, A. J. Kim, W. H. Payne, K. W. Bock, U. Torian, I. N. Moore, A. K. Harris
This study examines how different structural arrangements of hemagglutinin (HA) in commercial influenza vaccines correlate with the induction of cross-reactive antibodies.
bioRxiv · Sep 22, 2022 · PreprintMicrobiology